Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Assessment of Proposed Revisions to the Youth Tobacco Survey: Impact on Measures of Youth Tobacco Use, Request for Application Number (RFA) DP07-001, 66534 [E6-19234]

Download as PDF 66534 Federal Register / Vol. 71, No. 220 / Wednesday, November 15, 2006 / Notices ESTIMATE OF ANNUALIZED BURDEN HOURS—Continued Number of respondents Form CJD ................................................................................................................ Cyclosporiasis ................................................................................................ Dengue Case Investigation ........................................................................... Hantavirus Pulmonary Syndrome .................................................................. Idiopathic CD4+T-lymphocytopenia ............................................................... Kawasaki Syndrome ...................................................................................... Legionellosis Case Report ............................................................................. Lyme Disease Report .................................................................................... Malaria Case Surveillance Report ................................................................. Plague Case Investigation Report ................................................................. Q Fever .......................................................................................................... Reye Syndrome Case Surveillance Report ................................................... Tick-borne Rickettsial Disease Case Report ................................................. Trichinosis Surveillance Case Report ............................................................ Tularemia ....................................................................................................... Typhoid Fever Surveillance Report ............................................................... Viral Hepatitis Case Record .......................................................................... Dated: November 8, 2006. Joan F. Karr, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E6–19263 Filed 11–14–06; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention rmajette on PROD1PC67 with NOTICES1 Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Assessment of Proposed Revisions to the Youth Tobacco Survey: Impact on Measures of Youth Tobacco Use, Request for Application Number (RFA) DP07–001 In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces a meeting of the aforementioned Special Emphasis Panel. Time and Date: 2:30 p.m.–5:30 p.m., December 12, 2006 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters To Be Discussed: The meeting will include the review, discussion, and evaluation of research grant applications in response to RFA DP07–001, ‘‘Assessment of Proposed Revisions to VerDate Aug<31>2005 15:00 Nov 14, 2006 Jkt 211001 20 55 55 46 10 55 23 52 55 55 55 50 55 55 55 55 55 the Youth Tobacco Survey: Impact on Measures of Youth Tobacco Use.’’ For Further Information Contact: Brenda Colley Gilbert, Acting Director, Office of Extramural Research, National Center for Chronic Disease Prevention and Health Promotion, 4770 Buford Highway, NE., MS K92, Atlanta, GA 30341, telephone 770.488.8390. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: November 8, 2006. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E6–19234 Filed 11–14–06; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Occupational Health and Safety Research, Member Conflict, Program Announcement (PA) 04–038 In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces a meeting of the aforementioned Special Emphasis Panel. PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 Number responses/ respondent Total responses 2 10 182 3 2 8 11.7 385 20 0.20 1 1 18 .45 2.2 6 200 40 550 10,010 138 20 440 269 20,020 1,100 11 55 50 990 25 121 330 11,000 Hrs/response 20/60 15/60 15/60 20/60 10/60 15/60 20/60 10/60 15/60 20/60 10/60 20/60 10/60 20/60 20/60 20/60 25/60 Time and Date: 1 p.m.–2:30 p.m., November 28, 2006 (Closed). Place: Teleconference. National Institute for Occupational Safety and Health, CDC, 2400 Century Parkway, NE., Atlanta, GA 30345. Status: The meeting will be closed to the public in accordance with provisions set forth in section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters To Be Discussed: The meeting will include the review, discussion, and evaluation of research grant applications in response to ‘‘Occupational Health and Safety Research,’’ PA 04–038. For Further Information Contact: Charles N. Rafferty, Ph.D., Designated Federal Official, 100 Clifton Road, Mailstop E–74, Atlanta, GA 30333, telephone (404) 498–2582. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: November 8, 2006. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E6–19235 Filed 11–14–06; 8:45 am] BILLING CODE 4163–18–P E:\FR\FM\15NON1.SGM 15NON1

Agencies

[Federal Register Volume 71, Number 220 (Wednesday, November 15, 2006)]
[Notices]
[Page 66534]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-19234]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel: Assessment of Proposed Revisions to the Youth Tobacco 
Survey: Impact on Measures of Youth Tobacco Use, Request for 
Application Number (RFA) DP07-001

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces a meeting of the aforementioned Special 
Emphasis Panel.
    Time and Date: 2:30 p.m.-5:30 p.m., December 12, 2006 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance with 
provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and 
the Determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the review, 
discussion, and evaluation of research grant applications in response 
to RFA DP07-001, ``Assessment of Proposed Revisions to the Youth 
Tobacco Survey: Impact on Measures of Youth Tobacco Use.''
    For Further Information Contact: Brenda Colley Gilbert, Acting 
Director, Office of Extramural Research, National Center for Chronic 
Disease Prevention and Health Promotion, 4770 Buford Highway, NE., MS 
K92, Atlanta, GA 30341, telephone 770.488.8390.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both CDC and the Agency for Toxic Substances and Disease Registry.

    Dated: November 8, 2006.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. E6-19234 Filed 11-14-06; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.